Tech Company Financing Transactions
BioAmber Funding Round
BioAmber closed a $30 million Series C investment round on 2/23/2012. Investors included Lanxess AG , Mitsui & Co. and NAXOS Capital Partners.
Transaction Overview
Company Name
Announced On
2/23/2012
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series C
Investors
Proceeds Purpose
Our investment in BioAmber shows our commitment to launching a new generation of plasticizers that satisfy regulatory requirements and can also score in terms of sustainability.
Company Information
Company Status
Publicly-held
Industry
Clean Tech
Mailing Address
1250 René-Lévesque Blvd. West 4310
Montreal QC, H3B 4W8
Canada
Montreal QC, H3B 4W8
Canada
Phone
Website
Email Address
Not Recorded
Overview
BioAmber is a sustainable chemicals company. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into chemicals for use in a wide variety of everyday products including plastics, resins, food additives and personal care products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jean-François Huc
Chief Financial Officer
Andrew Ashworth
Chief Technical Officer
Jim Millis
Executive Vice President
Mike Hartmann
VP - Sales
Babette Pettersen
Browse more venture capital transactions:
Prev: 2/23/2012: Resonate Networks venture capital transaction
Next: 2/23/2012: Lumesis venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs